Catenabio

Developer of antibody-drug conjugates for the treatment of multiple diseases

placeBerkeley, California, United States calendar_todayFounded 2020 groups8 employees language catenabio.com

Registered entities

Social engagement

Social engagement: 2.4K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record.

Investor typeCountShare
Venture capital1280%
Accelerator & incubator17%
Other / undisclosed213%

Recent activity

12 May 2026
Event
PEGS Boston
Coming soon